Neostriatal glutamatergic system is involved in the pathogenesis of picrotoxin-induced choreomyoclonic hyperkinesis
- 1 December 2004
- journal article
- physiology
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 138 (6) , 533-536
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Evidence for more widespread cerebral pathology in early HDNeurology, 2003
- Huntington’s diseaseNeurology, 2002
- Does tissue transglutaminase play a role in Huntington's disease?Neurochemistry International, 2002
- Age-Related Changes in the N-Methyl-d-aspartate Receptor Binding Sites within the Human Basal GangliaExperimental Neurology, 2001
- Distinct Roles of Synaptic and Extrasynaptic NMDA Receptors in ExcitotoxicityThe Journal of Neuroscience, 2000
- 1 H NMR spectroscopy studies of Huntington's diseaseNeurology, 1998
- Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntingtonʼs Disease—An In Situ Hybridization StudyJournal of Neuropathology & Experimental Neurology, 1997
- Selective Loss of [3H]Kainic Acid and [3H]AMPA Binding in Layer VI of Frontal Cortex in Huntington's DiseaseExperimental Neurology, 1994
- What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studiesNeurology, 1990
- Neuropathological Classification of Huntingtonʼs DiseaseJournal of Neuropathology & Experimental Neurology, 1985